FDA
approval
· 2024-02-15
FDA Approved: PREMARIN VAGINAL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
Summary
FDA approved a supplemental application for Premarin Vaginal (conjugated estrogens) from Wyeth/Pfizer, updating labeling for the product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for PREMARIN VAGINAL (CONJUGATED ESTROGENS)